Community/Retail

QS/1, a health care software solutions company, is partnering with Digital Pharmacist, Inc. to offer secure, HIPAA-compliant methods of patient communication through a variety of platforms.

Officials with the FDA have permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes.

The flu vaccine prevented 7.1 million illnesses, according to the analysis, along with 109,000 hospitalizations, and 8000 deaths, during the 2017-2018 influenza season.

Some pharmacists are not taking the time to stay hydrated and use the restroom, which can lead to serious health consequences.

Alipay will be available at more than 7,000 stores nationwide.

Officials with the FDA have approved Novartis’ triclabendazole (Egaten) for the treatment of fascioliasis, also known as liver fluke infestation, in patients age 6 years and older.

Ryan, who was elected as the 54th Speaker of the House in 2015 and served in that role until January 2019 will speak as part of the Business Program, scheduled for Tuesday April 30.

An FDA program is seeking to facilitate better quality drug manufacturing through recognized consensus standards.

Amid a global measles outbreak, some teenagers are questioning their anti-vaxxer parents about not vaccinating them against many dangerous and deadly diseases.

Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia & Upjohn).

Pharmacy DIR fees increasingly are being misused by payers to retroactively claw back reimbursement to pharmacies for the prescription drugs that they provide to Medicare beneficiaries.

An FDA Advisory Committee has recommended the agency’s approval of Janssen’s esketamine nasal spray CIII (Spravato) for adults living with treatment-resistant depression.

The generic product (Wixela Inhub, Mylan) will be offered in 3 strengths at wholesale acquisition costs that are 70% less than the brand equivalent Advair Diskus, according to Mylan.

Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.

ICI therapy offers a new way to treat cancer, yet clinical trials have often excluded those with HIV due to concerns that it may have negative effects, such as virus reactivation.

Flouxetine tablets were approved with the indication of treating multiple mental disorders.

Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.

The collaborating drug companies cut prices in an effort to make their drugs more accessible.

Warning letters and online advisory letters were posted to the agency's website for 58 products, mostly dietary supplements.

Can you solve why this lady had a mysterious heart attack?

Pulmatrix is set to launch a clinical investigation on the product in 2019.

Researchers predict that the changing nature of the epidemic, driven by the illegal use of opioids such as heroin and fentanyl, has reduced the potential impact of programs that target prescription opioids.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

The program aims to reduce the amount of illegal or suspect prescription drugs distributed throughout the United States.

The risks are too high for the pharmacy to be cavalier regarding compliance with antifraud laws.

Patients with chronic obstructive pulmonary disease (COPD) who receive a flu vaccine are significantly less likely to be hospitalized with influenza.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, has announced the ninth annual Directions in Pharmacy® continuing education conference series, which will take place in 4 major cities across the United States in spring 2019.